Cell

, volume 187 , issue 25 , pages 7143-7163.e22

Multiscale drug screening for cardiac fibrosis identifies MD2 as a therapeutic target

Hao Zhang ^{1, 2, 3}

Phung N Thai ^{4, 5}

Rabindra V Shivnaraine ⁶

Ren Lu ^{1, 2, 3}

Xuekun Wu ^{1, 2, 3}

Dirk H Siepe ⁷

Yu Liu ^{1, 2, 3}

CHENGYI TU ^{1, 2, 3}

Hye Sook Shin ^{1, 2, 3}

Arianne Caudal ^{1, 2, 3}

Souhrid Mukherjee ⁶

Jeremy Leitz ⁶

Wilson Tan Lek Wen ^{1, 2, 3}

Wenqiang Liu ^{1, 2, 3}

Wenjuan Zhu ^{1, 2, 3}

Nipavan Chiamvimonvat ^{4, 8}

Joseph C. Wu ^{1, 2, 3}

Hide authors affiliations Show authors affiliations: 8 affiliations

Stanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, CA 94305, USA |

Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA |

Department of Medicine, Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA |

⁴

Department of Internal Medicine, Division of Cardiovascular Medicine, University of California, Davis, Davis, CA 95616, USA |

⁵

David Geffen School of Medicine at University of California, Los Angeles, CA 90095, USA |

⁶

Greenstone Biosciences, Palo Alto, CA 94305, USA |

⁷

Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA |

⁸

Department of Basic Medical Sciences and Translational Cardiovascular Research Center, University of Arizona College of Medicine, Phoenix, AZ 85004, USA |

Publication type: Journal Article

Publication date: 2024-12-01

Elsevier

Cell

scimago Q1

wos Q1

SJR: 22.612

CiteScore: 74.8

Impact factor: 42.5

ISSN: 00928674, 10974172

DOI: 10.1016/j.cell.2024.09.034

Copy DOI

PubMed ID: 39413786

Found

Top-30

Journals

	1 2
Journal of Advanced Research	Journal of Advanced Research, 2, 5% Journal of Advanced Research 2 publications, 5%
International Journal of Molecular Sciences	International Journal of Molecular Sciences, 2, 5% International Journal of Molecular Sciences 2 publications, 5%
Pharmaceuticals	Pharmaceuticals, 2, 5% Pharmaceuticals 2 publications, 5%
Advanced Science	Advanced Science, 2, 5% Advanced Science 2 publications, 5%
Nature Communications	Nature Communications, 2, 5% Nature Communications 2 publications, 5%
Nature Reviews Drug Discovery	Nature Reviews Drug Discovery, 1, 2.5% Nature Reviews Drug Discovery 1 publication, 2.5%
Bioorganic Chemistry	Bioorganic Chemistry, 1, 2.5% Bioorganic Chemistry 1 publication, 2.5%
Signal Transduction and Targeted Therapy	Signal Transduction and Targeted Therapy, 1, 2.5% Signal Transduction and Targeted Therapy 1 publication, 2.5%
Regenerative Medicine Reports	Regenerative Medicine Reports, 1, 2.5% Regenerative Medicine Reports 1 publication, 2.5%
Circulation Research	Circulation Research, 1, 2.5% Circulation Research 1 publication, 2.5%
Clinical and Translational Medicine	Clinical and Translational Medicine, 1, 2.5% Clinical and Translational Medicine 1 publication, 2.5%
Circulation	Circulation, 1, 2.5% Circulation 1 publication, 2.5%
Biomedicine and Pharmacotherapy	Biomedicine and Pharmacotherapy, 1, 2.5% Biomedicine and Pharmacotherapy 1 publication, 2.5%
Chinese Medicine	Chinese Medicine, 1, 2.5% Chinese Medicine 1 publication, 2.5%
Life Sciences	Life Sciences, 1, 2.5% Life Sciences 1 publication, 2.5%
Bioorganic and Medicinal Chemistry Letters	Bioorganic and Medicinal Chemistry Letters, 1, 2.5% Bioorganic and Medicinal Chemistry Letters 1 publication, 2.5%
Cardiovascular Research	Cardiovascular Research, 1, 2.5% Cardiovascular Research 1 publication, 2.5%
Cell Death and Disease	Cell Death and Disease, 1, 2.5% Cell Death and Disease 1 publication, 2.5%
Journal of Cardiovascular Translational Research	Journal of Cardiovascular Translational Research, 1, 2.5% Journal of Cardiovascular Translational Research 1 publication, 2.5%
Drug Discovery Today	Drug Discovery Today, 1, 2.5% Drug Discovery Today 1 publication, 2.5%
International Immunopharmacology	International Immunopharmacology, 1, 2.5% International Immunopharmacology 1 publication, 2.5%
Trends in Pharmacological Sciences	Trends in Pharmacological Sciences, 1, 2.5% Trends in Pharmacological Sciences 1 publication, 2.5%
Biomolecules	Biomolecules, 1, 2.5% Biomolecules 1 publication, 2.5%
iScience	iScience, 1, 2.5% iScience 1 publication, 2.5%
Phytotherapy Research	Phytotherapy Research, 1, 2.5% Phytotherapy Research 1 publication, 2.5%
Journal of the Mechanics and Physics of Solids	Journal of the Mechanics and Physics of Solids, 1, 2.5% Journal of the Mechanics and Physics of Solids 1 publication, 2.5%
JDS Communications	JDS Communications, 1, 2.5% JDS Communications 1 publication, 2.5%
Cellular Signalling	Cellular Signalling, 1, 2.5% Cellular Signalling 1 publication, 2.5%
Journal of Clinical Investigation	Journal of Clinical Investigation, 1, 2.5% Journal of Clinical Investigation 1 publication, 2.5%
	1 2

Publishers

	2 4 6 8 10 12 14
Elsevier	Elsevier, 13, 32.5% Elsevier 13 publications, 32.5%
Springer Nature	Springer Nature, 8, 20% Springer Nature 8 publications, 20%
MDPI	MDPI, 5, 12.5% MDPI 5 publications, 12.5%
Wiley	Wiley, 4, 10% Wiley 4 publications, 10%
Ovid Technologies (Wolters Kluwer Health)	Ovid Technologies (Wolters Kluwer Health), 3, 7.5% Ovid Technologies (Wolters Kluwer Health) 3 publications, 7.5%
Cold Spring Harbor Laboratory	Cold Spring Harbor Laboratory, 3, 7.5% Cold Spring Harbor Laboratory 3 publications, 7.5%
Oxford University Press	Oxford University Press, 1, 2.5% Oxford University Press 1 publication, 2.5%
American Dairy Science Association	American Dairy Science Association, 1, 2.5% American Dairy Science Association 1 publication, 2.5%
American Society for Clinical Investigation	American Society for Clinical Investigation, 1, 2.5% American Society for Clinical Investigation 1 publication, 2.5%
American Chemical Society (ACS)	American Chemical Society (ACS), 1, 2.5% American Chemical Society (ACS) 1 publication, 2.5%
	2 4 6 8 10 12 14

We do not take into account publications without a DOI.
Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.

Metrics

Cite this

GOST |

Cite this

GOST Copy

Zhang H. et al. Multiscale drug screening for cardiac fibrosis identifies MD2 as a therapeutic target // Cell. 2024. Vol. 187. No. 25. p. 7143-7163.e22.

GOST all authors (up to 50) Copy

Zhang H., Thai P. N., Shivnaraine R. V., Lu R., Wu X., Siepe D. H., Liu Yu., TU C., Shin H. S., Caudal A., Mukherjee S., Leitz J., Wen W. T. L., Liu W., Zhu W., Chiamvimonvat N., Wu J. C. Multiscale drug screening for cardiac fibrosis identifies MD2 as a therapeutic target // Cell. 2024. Vol. 187. No. 25. p. 7143-7163.e22.

RIS |

Cite this

RIS Copy

TY - JOUR

DO - 10.1016/j.cell.2024.09.034

UR - https://linkinghub.elsevier.com/retrieve/pii/S0092867424010924

TI - Multiscale drug screening for cardiac fibrosis identifies MD2 as a therapeutic target

T2 - Cell

AU - Zhang, Hao

AU - Thai, Phung N

AU - Shivnaraine, Rabindra V

AU - Lu, Ren

AU - Wu, Xuekun

AU - Siepe, Dirk H

AU - Liu, Yu

AU - TU, CHENGYI

AU - Shin, Hye Sook

AU - Caudal, Arianne

AU - Mukherjee, Souhrid

AU - Leitz, Jeremy

AU - Wen, Wilson Tan Lek

AU - Liu, Wenqiang

AU - Zhu, Wenjuan

AU - Chiamvimonvat, Nipavan

AU - Wu, Joseph C.

PY - 2024

DA - 2024/12/01

PB - Elsevier

SP - 7143-7163.e22

IS - 25

VL - 187

PMID - 39413786

SN - 0092-8674

SN - 1097-4172

ER -

BibTex |

Cite this

BibTex (up to 50 authors) Copy

@article{2024_Zhang,

author = {Hao Zhang and Phung N Thai and Rabindra V Shivnaraine and Ren Lu and Xuekun Wu and Dirk H Siepe and Yu Liu and CHENGYI TU and Hye Sook Shin and Arianne Caudal and Souhrid Mukherjee and Jeremy Leitz and Wilson Tan Lek Wen and Wenqiang Liu and Wenjuan Zhu and Nipavan Chiamvimonvat and Joseph C. Wu},

title = {Multiscale drug screening for cardiac fibrosis identifies MD2 as a therapeutic target},

journal = {Cell},

year = {2024},

volume = {187},

publisher = {Elsevier},

month = {dec},

url = {https://linkinghub.elsevier.com/retrieve/pii/S0092867424010924},

number = {25},

pages = {7143--7163.e22},

doi = {10.1016/j.cell.2024.09.034}

}

MLA

Cite this

MLA Copy

Zhang, Hao, et al. “Multiscale drug screening for cardiac fibrosis identifies MD2 as a therapeutic target.” Cell, vol. 187, no. 25, Dec. 2024, pp. 7143-7163.e22. https://linkinghub.elsevier.com/retrieve/pii/S0092867424010924.

Publisher

Elsevier

Journal

Cell

scimago Q1

wos Q1

SJR

22.612

CiteScore

74.8

Impact factor

42.5

ISSN

00928674 (Print)

10974172 (Electronic)

Profiles